当前位置:首页 - 行情中心 - 海螺新材(000619) - 财务分析 - 利润表

海螺新材

(000619)

  

流通市值:21.89亿  总市值:26.82亿
流通股本:3.60亿   总股本:4.41亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入1,028,171,837.735,276,178,312.184,087,624,638.172,658,853,425.12
营业收入1,028,171,837.735,276,178,312.184,087,624,638.172,658,853,425.12
二、营业总成本1,069,623,657.875,392,316,123.354,137,562,087.782,686,966,742.65
营业成本955,891,067.144,856,621,6203,748,740,652.342,434,609,462.8
税金及附加8,756,265.7839,240,603.629,371,291.518,242,623.86
销售费用33,670,159.88161,851,117.3119,954,321.9376,261,831.12
管理费用54,926,607.92260,346,317.13175,857,899.86113,179,818.13
研发费用10,046,097.7242,712,820.6941,378,257.6527,225,830.66
财务费用6,333,459.4331,543,644.6322,259,664.517,447,176.08
其中:利息费用8,755,808.5744,342,107.9734,653,645.7522,516,600.2
其中:利息收入2,033,697.848,214,463.956,479,845.45,306,722.51
加:投资收益1,401,842.864,095,660.324,321,382.222,510,000
资产处置收益96,081.72423,228.98165,282.98133,607.83
资产减值损失(新)1,157,861.61-9,010,535.612,918,834.262,918,834.26
信用减值损失(新)890,994.88-17,887,227.86-3,530,752.97-3,565,630
其他收益12,285,075.5636,907,939.9428,590,903.2922,199,496.14
营业利润平衡项目0000
四、营业利润-25,619,963.51-101,608,745.4-17,471,799.83-3,917,009.3
加:营业外收入378,165.51,577,409.73813,970.58313,421.95
减:营业外支出62,621.14866,968.8195,741.69115,206.48
利润总额平衡项目0000
五、利润总额-25,304,419.15-100,898,304.47-16,853,570.94-3,718,793.83
减:所得税费用1,358,318.9410,844,177.57,179,896.285,830,058.02
六、净利润-26,662,738.09-111,742,481.97-24,033,467.22-9,548,851.85
持续经营净利润-26,662,738.09-111,742,481.97-24,033,467.22-9,548,851.85
归属于母公司股东的净利润-24,555,074.25-105,860,431.71-26,412,465.06-12,044,942.53
少数股东损益-2,107,663.84-5,882,050.262,378,997.842,496,090.68
(一)基本每股收益-0.06-0.24-0.06-0.03
(二)稀释每股收益-0.06-0.24-0.06-0.03
八、其他综合收益--9,064,403.22--
归属于母公司股东的其他综合收益--3,109,243.07--
九、综合收益总额-26,662,738.09-120,806,885.19-24,033,467.22-9,548,851.85
归属于母公司股东的综合收益总额-24,555,074.25-108,969,674.78-26,412,465.06-12,044,942.53
归属于少数股东的综合收益总额-2,107,663.84-11,837,210.412,378,997.842,496,090.68
公告日期2025-04-252025-03-292024-10-262024-08-24
审计意见(境内)标准无保留意见
TOP↑